Acrivon Therapeutics Inc. (ACRV) Social Stream
ACRIVON THERAPEUTICS INC (ACRV) Price Targets From Analysts
Use the tables below to see what analysts covering ACRIVON THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-12 | 3 | $25 | $17 | $21 | $4.98 | 321.69% |
| 2023-03-29 | 3 | $26 | $17 | $21.5 | $4.98 | 331.73% |
| 2023-04-20 | 4 | $26 | $17 | $22.333 | $4.98 | 348.45% |
| 2023-05-09 | 5 | $26 | $17 | $22.25 | $4.98 | 346.79% |
| 2023-05-10 | 6 | $26 | $17 | $21.5 | $4.98 | 331.73% |
| 2023-06-02 | 7 | $26 | $17 | $22.2 | $4.98 | 345.78% |
| 2023-08-14 | 7 | $26 | $17 | $22.666 | $4.98 | 355.14% |
| 2023-09-06 | 8 | $26 | $17 | $22.5 | $4.98 | 351.81% |
| 2023-11-09 | 8 | $26 | $17 | $22.714 | $4.98 | 356.1% |
| 2023-11-10 | 8 | $26 | $17 | $22.571 | $4.98 | 353.23% |
| 2023-11-15 | 8 | $26 | $17 | $22 | $4.98 | 341.77% |
| 2023-12-15 | 8 | $26 | $12 | $21.285 | $4.98 | 327.41% |
| NA | 3 | $NA | $NA | $NA | $4.98 | NA% |
The Trend in the Analyst Price Target
Over the past 12 months, ACRV's average price target has gone up $0.29.
Over the past 37 weeks, ACRV's average upside potential has been 163.94%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-29 | 3 | 26 | 17 | 21.500 | 12.71 | 69.16% |
| 2023-06-02 | 7 | 26 | 17 | 22.666 | 12.37 | 83.23% |
| 2023-09-06 | 7 | 26 | 17 | 22.500 | 11.90 | 89.08% |
| 2023-10-13 | 8 | 26 | 17 | 22.714 | 6.06 | 274.82% |
| 2023-11-09 | 8 | 26 | 17 | 22.714 | 4.59 | 394.86% |
ACRV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 8 | 0 | 0 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
ACRV's average broker recommendation rating improved by 0 over the prior 52 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- ACRIVON THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1476.78% of all US stocks.
- ACRV has a greater number of analysts covering the stock than 1515.33% of stocks in the micro market cap category.
- ACRV has a higher average analyst price target than 1299.56% of stocks in the micro market cap category.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ACRIVON THERAPEUTICS INC's variance in analysts' estimates is lower than -314.26% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ACRIVON THERAPEUTICS INC are COYA, SMFL, and XTLB.
View All Top Stocks by Price Target
Is ACRV a Buy, Hold or Sell? See the POWR Ratings now!